ReviewClinical and translational science2026
Understanding Postmarketing Requirements and Commitments for CYP3A-Mediated Drug-Drug Interactions: An Analysis of FDA-Approved Drugs From 2015 to 2024.
Jingjing Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.